Raltegravir EP Impurity E

Catalog No.	KMR019011
CAS No.	1193687-87-4
Alt. name	Raltegravir USP Related Compound E
Formula	C20H22N6O5
FW	426.4

Unit	Price	Stock
100 mg	Enquire	Enquire

Chemical Name:	N-benzyl-5-hydroxy-1-methyl-2-[2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide (as per EP); N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide (as per USP)
Purity:	>95%
Storage:	Store at 2-8 deg. C for long term storage
Shipping:	Product is stable to be Shipped at Room Temperature

Download MSDS

Raltegravir EP Impurity E is chemically N-benzyl-5-hydroxy-1-methyl-2-[2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide (as per EP); N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide (as per USP) . Raltegravir EP Impurity E is supplied with detailed characterization data compliant with regulatory guideline. Raltegravir EP Impurity E can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Raltegravir EP Impurity E.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.